The pivotal role of cholesterol absorption inhibitors in the management of dyslipidemia
<p>Abstract</p> <p>Elevated low-density lipoprotein (LDL)-cholesterol is associated with a significantly increased risk of coronary heart disease. Ezetimibe is the first member of a new class of selective cholesterol absorption inhibitors. It impairs the intestinal reabsorption of...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-10-01
|
Series: | Lipids in Health and Disease |
Subjects: | |
Online Access: | http://www.lipidworld.com/content/3/1/22 |